Cargando…

Unique product quality considerations in vaccine development, registration and new program implementation in Malaysia

This review aims to present the unique considerations for manufacturing and the regulation of new vaccines in Muslim-populated countries such as Malaysia. Our specific objectives are to highlight vaccine production and the ingredients of concern, summarize the current mechanism for ruling and recomm...

Descripción completa

Detalles Bibliográficos
Autores principales: Khoo, Yvonne S. K., Ghani, A. Ab, Navamukundan, A. A., Jahis, R., Gamil, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227723/
https://www.ncbi.nlm.nih.gov/pubmed/31652090
http://dx.doi.org/10.1080/21645515.2019.1667206
_version_ 1783534547738034176
author Khoo, Yvonne S. K.
Ghani, A. Ab
Navamukundan, A. A.
Jahis, R.
Gamil, A.
author_facet Khoo, Yvonne S. K.
Ghani, A. Ab
Navamukundan, A. A.
Jahis, R.
Gamil, A.
author_sort Khoo, Yvonne S. K.
collection PubMed
description This review aims to present the unique considerations for manufacturing and the regulation of new vaccines in Muslim-populated countries such as Malaysia. Our specific objectives are to highlight vaccine production and the ingredients of concern, summarize the current mechanism for ruling and recommendations on new vaccines, outline the different steps in decision-making on incorporating a new vaccine into the National Immunization Program, describe its issues and challenges, and explore the commercial viability and challenges of producing local permissible (halal) vaccines. Through this review, we hope readers understand that alternatives are present to replace ingredients of concern in vaccines. Halal certification and introduction of a new vaccine into a program are strictly conducted and health-care providers must be prepared to educate the public on this. At the same time, it is hoped that the production of halal vaccine in Malaysia will promote self-reliance in Muslim-populated countries.
format Online
Article
Text
id pubmed-7227723
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-72277232020-05-20 Unique product quality considerations in vaccine development, registration and new program implementation in Malaysia Khoo, Yvonne S. K. Ghani, A. Ab Navamukundan, A. A. Jahis, R. Gamil, A. Hum Vaccin Immunother Review This review aims to present the unique considerations for manufacturing and the regulation of new vaccines in Muslim-populated countries such as Malaysia. Our specific objectives are to highlight vaccine production and the ingredients of concern, summarize the current mechanism for ruling and recommendations on new vaccines, outline the different steps in decision-making on incorporating a new vaccine into the National Immunization Program, describe its issues and challenges, and explore the commercial viability and challenges of producing local permissible (halal) vaccines. Through this review, we hope readers understand that alternatives are present to replace ingredients of concern in vaccines. Halal certification and introduction of a new vaccine into a program are strictly conducted and health-care providers must be prepared to educate the public on this. At the same time, it is hoped that the production of halal vaccine in Malaysia will promote self-reliance in Muslim-populated countries. Taylor & Francis 2019-10-25 /pmc/articles/PMC7227723/ /pubmed/31652090 http://dx.doi.org/10.1080/21645515.2019.1667206 Text en © 2019 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Review
Khoo, Yvonne S. K.
Ghani, A. Ab
Navamukundan, A. A.
Jahis, R.
Gamil, A.
Unique product quality considerations in vaccine development, registration and new program implementation in Malaysia
title Unique product quality considerations in vaccine development, registration and new program implementation in Malaysia
title_full Unique product quality considerations in vaccine development, registration and new program implementation in Malaysia
title_fullStr Unique product quality considerations in vaccine development, registration and new program implementation in Malaysia
title_full_unstemmed Unique product quality considerations in vaccine development, registration and new program implementation in Malaysia
title_short Unique product quality considerations in vaccine development, registration and new program implementation in Malaysia
title_sort unique product quality considerations in vaccine development, registration and new program implementation in malaysia
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227723/
https://www.ncbi.nlm.nih.gov/pubmed/31652090
http://dx.doi.org/10.1080/21645515.2019.1667206
work_keys_str_mv AT khooyvonnesk uniqueproductqualityconsiderationsinvaccinedevelopmentregistrationandnewprogramimplementationinmalaysia
AT ghaniaab uniqueproductqualityconsiderationsinvaccinedevelopmentregistrationandnewprogramimplementationinmalaysia
AT navamukundanaa uniqueproductqualityconsiderationsinvaccinedevelopmentregistrationandnewprogramimplementationinmalaysia
AT jahisr uniqueproductqualityconsiderationsinvaccinedevelopmentregistrationandnewprogramimplementationinmalaysia
AT gamila uniqueproductqualityconsiderationsinvaccinedevelopmentregistrationandnewprogramimplementationinmalaysia